Analyst
Systematics
Equibles does not estimate personal net worth.
Vishal Manchanda is recorded as Analyst at Systematics. Vishal Manchanda has spoken on 5 earnings calls across 5 companies, most recently for Dr Reddys Laboratories Ltd on October 23, 2026. Those appearances were for Dr Reddys Laboratories Ltd (RDY), Orchid Pharma Limited, Sun Pharmaceutical Industries Limited, Cipla Limited and Shilpa Medicare Limited. The companies whose calls Vishal Manchanda spoke on are classified in the Healthcare sector.
“On Rituximab, would it be possible for you to share where are we in terms of market share in Europe?”
“On C7ACA, have you seen any material price changes on a quarter-over-quarter basis?”
“So, can you provide what share UnlockSet would have in terms of the various PD-L1 enumators among the new patients that get into the therapy?”
“On your gross margins, you highlighted certain inventory write-offs in your opening comments. So, can you talk about that? How much was that? And also quantify the impact of the inflation on the gross margins?”
“On roti protein patch Europe launch, can you share like what time can we take to reach full potential and any sense on the peak potential that you expect from the product?”
Systematics
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
Orchid Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Cipla Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Shilpa Medicare Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended June 30, 2026
Orchid Pharma Limited
Sun Pharma Q1 FY27 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
Earnings Call
Cipla Limited
Earnings Call
Shilpa Medicare Limited
